ACORDA.COM KEYWORD DENSITY CHECKER

Total words: 1741 | 2-word phrases: 461 | 3-word phrases: 496 | 4-word phrases: 516

PAGE INFO

Title Try to keep the title under 60 characters (80 characters)
Acorda Therapeutics Biotechnology Company | MS and Spinal Cord Injury Treatments
Description Try to keep the meta description between 50 - 160 characters (143 characters)
Acorda is a biotechnology company developing and commercializing neurology therapies for Parkinson’s disease, migraine and multiple sclerosis
Keywords Meta keywords are not recommended anymore (143 characters)
biotechnology company multiple sclerosis ms spinal cord injury acorda therapeutics injuries biomedical engineering companies treatment drugs acute biopharmaceutical industry pharmaceuticals pharma drug therapy treatments therapies
H1 H1 tag on the page (19 characters)
Products & Research

ONE WORD PHRASES 268 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1to207.46%
2acorda176.34%
3the155.60%
4of114.10%
5and114.10%
6investor93.36%
7information93.36%
8more82.99%
9learn82.99%
10on72.61%

TWO WORD PHRASES 461 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1learn more71.52%
2more ›61.30%
3acorda the51.08%
4about acorda51.08%
5for patients40.87%
6in the40.87%
7acorda therapeutics40.87%
8contact us40.87%
9financial information30.65%
10investor resources30.65%
11resources investor30.65%
12is a30.65%
13reports annual20.43%
14awards press20.43%
15events investor20.43%
16news awards20.43%
17newsevents in20.43%
18ir contact20.43%
19faqs ir20.43%
20alerts faqs20.43%

THREE WORD PHRASES 496 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1learn more ›61.21%
2at acorda our20.40%
3information investor events20.40%
4quarterly reports annual20.40%
5information quarterly reports20.40%
6financial information quarterly20.40%
7map contact us20.40%
8events investor news20.40%
9investor events investor20.40%
10healthcare professionals and20.40%
11annual reports sec20.40%
12corporate governance stock20.40%
13see the video20.40%
14medicines products investors20.40%
15unapproved or uncommercialized20.40%
16to unapproved or20.40%
17working at acorda20.40%
18resources policy on20.40%
19community resources policy20.40%
20reports annual reports20.40%
21reports sec filings20.40%
22on therapies in20.40%
23newsevents in the20.40%
24acorda our employees20.40%
25social media careers20.40%
26releases social media20.40%
27benefits job openings20.40%
28news awards press20.40%
29the news awards20.40%
30in the news20.40%

FOUR WORD PHRASES 516 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1analysts investor resources investor20.39%
2in the news awards20.39%
3cookie notice terms of20.39%
4disorders learn more ›20.39%
5acorda compliance message from20.39%
6compliance message from bio20.39%
7message from bio diversity20.39%
8from bio diversity and20.39%
9bio diversity and inclusion20.39%
10newsevents in the news20.39%
11the news awards press20.39%
12directors grant program compliance20.39%
13releases social media careers20.39%
14for patients focus on20.39%
15patients focus on therapies20.39%
16focus on therapies in20.39%
17on therapies in the20.39%
18at acorda our employees20.39%
19working at acorda our20.39%
20to unapproved or uncommercialized20.39%
21community resources policy on20.39%
22notice terms of use20.39%
23terms of use site20.39%
24of directors grant program20.39%
25alerts faqs ir contact20.39%
26investor resources investor kit20.39%
27resources investor kit email20.39%
28annual reports sec filings20.39%
29reports annual reports sec20.39%
30quarterly reports annual reports20.39%
31information quarterly reports annual20.39%
32financial information quarterly reports20.39%
33board of directors grant20.39%
34access to unapproved or20.39%
35investor events investor news20.39%
36information investor events investor20.39%
37leadership management team board20.39%
38management team board of20.39%
39team board of directors20.39%
40benefits job openings acorda10.19%

EXTERNAL LINKS

# URL Whois Check